Ipsen Sa Stock Fundamentals
| I7G Stock | EUR 108.30 0.60 0.55% |
Ipsen SA fundamentals help investors to digest information that contributes to Ipsen SA's financial success or failures. It also enables traders to predict the movement of Ipsen Stock. The fundamental analysis module provides a way to measure Ipsen SA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ipsen SA stock.
Ipsen |
Ipsen SA Company Profit Margin Analysis
Ipsen SA's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Ipsen SA Profit Margin | 0.21 % |
Most of Ipsen SA's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ipsen SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Ipsen SA has a Profit Margin of 0.2055%. This is 101.83% lower than that of the Healthcare sector and 103.47% lower than that of the Drug Manufacturers - Specialty & Generic industry. The profit margin for all Germany stocks is 116.18% lower than that of the firm.
Ipsen SA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Ipsen SA's current stock value. Our valuation model uses many indicators to compare Ipsen SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ipsen SA competition to find correlations between indicators driving Ipsen SA's intrinsic value. More Info.Ipsen SA is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about 0.53 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Ipsen SA is roughly 1.89 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ipsen SA's earnings, one of the primary drivers of an investment's value.Ipsen Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ipsen SA's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ipsen SA could also be used in its relative valuation, which is a method of valuing Ipsen SA by comparing valuation metrics of similar companies.Ipsen SA is currently under evaluation in profit margin category among its peers.
Ipsen Fundamentals
| Return On Equity | 0.19 | |||
| Return On Asset | 0.1 | |||
| Profit Margin | 0.21 % | |||
| Operating Margin | 0.28 % | |||
| Current Valuation | 8.46 B | |||
| Shares Outstanding | 82.63 M | |||
| Shares Owned By Insiders | 57.12 % | |||
| Shares Owned By Institutions | 20.19 % | |||
| Price To Earning | 20.55 X | |||
| Price To Book | 2.88 X | |||
| Price To Sales | 2.54 X | |||
| Revenue | 3.16 B | |||
| Gross Profit | 2.63 B | |||
| EBITDA | 1.06 B | |||
| Net Income | 648.6 M | |||
| Cash And Equivalents | 264.1 M | |||
| Cash Per Share | 3.18 X | |||
| Total Debt | 562.8 M | |||
| Debt To Equity | 86.40 % | |||
| Current Ratio | 0.73 X | |||
| Book Value Per Share | 40.53 X | |||
| Cash Flow From Operations | 971.4 M | |||
| Earnings Per Share | 7.09 X | |||
| Number Of Employees | 5 K | |||
| Beta | 0.7 | |||
| Market Capitalization | 8.93 B | |||
| Total Asset | 5.61 B | |||
| Z Score | 9.0 | |||
| Annual Yield | 0.01 % | |||
| Five Year Return | 1.20 % | |||
| Net Asset | 5.61 B | |||
| Last Dividend Paid | 1.2 |
About Ipsen SA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ipsen SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ipsen SA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ipsen SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Ipsen S.A. operates as a biopharmaceutical company worldwide. Ipsen S.A. was founded in 1929 and is headquartered in Boulogne-Billancourt, France. IPSEN S operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 5700 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Ipsen Stock
Ipsen SA financial ratios help investors to determine whether Ipsen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ipsen with respect to the benefits of owning Ipsen SA security.